Abstract. Complete and continuous imaging of microvascular networks is crucial for a wide variety of biomedical applications. Photoacoustic tomography can provide high resolution microvascular imaging using hemoglobin within red blood cells ͑RBCs͒ as an endogenic contrast agent. However, intermittent RBC flow in capillaries results in discontinuous and fragmentary capillary images. To overcome this problem, we use Evans blue ͑EB͒ dye as a contrast agent for in vivo photoacoustic imaging. EB has strong optical absorption and distributes uniformly in the blood stream by chemically binding to albumin. With the help of EB, complete and continuous microvascular networks-especially capillaries-are imaged. The diffusion dynamics of EB leaving the blood stream and the clearance dynamics of the EB-albumin complex are also quantitatively investigated.
Introduction
In the last decade, photoacoustic ͑PA͒ tomography, which combines the spatial resolution of ultrasound imaging with the contrast of optical absorption in deep biological tissues, 1,2 has gained great attention in biomedical applications. 3, 4 Ultrasonic imaging yields better spatial resolution in deep tissues than optical techniques, because ultrasonic scattering is much weaker than optical scattering, 2 making possible image reconstruction based on propagated waves rather than energy diffusion. However, pure ultrasonic imaging is insensitive to early stage tumors and other biochemical properties, such as oxygen saturation or concentration of hemoglobin, because it is based on the detection of the bulk mechanical properties of biological tissues. By combining optical imaging with ultrasound, PA imaging can achieve both high contrast and high spatial resolution. PA imaging has been used for both structural and functional imaging of tumor, 5 brain cortex perfusion, 6 ,7 microvascular structure, 8 and hemoglobin concentration and oxygenation, 9 as well as for lymph flow cytometry. 10 Furthermore, it shows potential for blood flow measurement. 11, 12 Since the amplitude of the PA signal is proportional to the absorbed optical energy density ͑i.e., specific optical absorption͒, the PA technique has the advantage of directly measuring the absorption spectra in vivo, allowing better tissue identification and providing functional information. 2, 5, 9, 10 Thus PA imaging is complementary with other high resolution optical imaging modalities such as confocal microscopy, two-photon microscopy, and optical coherence tomography, which can provide in vivo imaging within the optical transport mean free path ͑ϳ1 mm͒ of biological tissues. 13 Previously, an optical-resolution confocal photoacoustic microscope ͑OR-PAM͒ was described, with a lateral resolution of 5 m, axial resolution of 15 m, and imaging depth greater than 0.7 mm. 8 OR-PAM is a good tool to image blood vessels at the capillary level. High spatial resolution of OR-PAM can resolve capillaries smaller than 10 m in diameter 14 using hemoglobin within red blood cells ͑RBCs͒ as an endogenic contrast agent.
However, RBC flow in capillaries is discontinuous and changes greatly over time. [15] [16] [17] Because RBCs are the only noticeable optical absorbers in capillaries, it is highly likely that no absorber is present in a particular voxel during the laser pulse, which results in discontinuous capillaries in a RBC-based PA image. To acquire a complete capillary image and gain information about the capillary's functional state, 18 the use of an exogenic contrast agent is compelling.
In this work we use Evans blue ͑EB͒ dye for this purpose. EB has strong absorption in visible and near-infrared light, with a peak at 620 nm. EB is nontoxic and is used in measurement of blood volume, 19 lymph node location, 20 microvascular permeability, 21, 22 blood-retinal barrier breakdown, 23 capillary perfusion, 17 and blood plasma flow, 15 among other applications. In the blood stream, EB mainly binds to serum albumin in a reversible manner, so it is uniformly distributed in the plasma, maximizing the chance to get a complete capillary network image. Under normal conditions, the EB-albumin ͑EBA͒ complex is confined to blood vessels, while the free dye more readily diffuses out into extravascular tissue. The diffused dye is bound to the surround-ing tissue proteins, and finally cleared out by either metabolism or excretion. [24] [25] [26] [27] This work seeks to achieve complete capillary network imaging, to quantitatively investigate the dynamic diffusion of EB out of the circulation system, and to elucidate the dynamic clearance of EBA.
Materials and Methods

Optical-Resolution Confocal Photoacoustic
Microscope System
The OR-PAM system used in this work has been described in detail previously. 8 Briefly, a Nd:YLF laser ͑INNOSLAB, 523 nm, Edgewave, Aachen, Germany͒ pumped a dye laser ͑CBR-D, Sirah, Karst, Germany͒ used as the irradiation source. To cover the wavelength requirement for both RBCs and EB, laser dye Pyrro597 ͑peak at 582 nm, tuning range 566 to 611 nm͒ was employed. The ϳ7-ns laser pulse was passed through a 25-m-diam pinhole and focused by a microscope objective lens ͑Olympus 4ϫ, NA= 0.1͒. The laser energy after the objective lens was ϳ100 nJ. Ultrasonic detection was achieved through a spherically focused ultrasonic transducer ͑V2012-BC, Panametrics-NDT, Olympus, focal spot size 27 m͒ with a center frequency of 75 MHz, and a roundtrip 6-dB bandwidth of 80%, placed confocally with the optical objective. The PA signal detected by the ultrasonic transducer was amplified, digitized, and saved. The laser power was monitored by a reference channel to compensate for laser power instability. A volumetric image was generated by recording the time-resolved PA signal ͑A-line͒ at each horizontal location of the 2-D raster scan.
Animal Preparation
The ears of adult, 6-to 8-week-old nude mice ͑Hsd: Athymic Nude-Foxl NU Harlan Company, Indianapolis, Indiana, body weight ϳ20 g͒ were used for all in vivo experiments here, because their small thickness allowed us to verify some of the PA results by using a standard bright field optical microscope. The nude mouse ear model has a well-developed vasculature and has been widely used to study tumor angiogenesis and other microvascular diseases. 28 Before data acquisition, the animal was anesthetized by an intraperitoneal injection of 85% ketamine and 15% xylazine ͑100-l / g body weight͒. During data acquisition, the animal was placed on a warming pad ͑37°C͒, and its head was held steady with a dental/hard palate fixture. The animal was kept still by using a breathing anesthesia system ͑E-Z Anesthesia, Euthanex, Palmer, Pennsylvania͒. After the experiment, the animal recovered naturally and was returned to its cage. All experimental animal procedures were carried out in conformity with the laboratory animal protocol approved by the Animal Studies Committee of the School of Medicine at Washington University in Saint Louis.
Mode of Injection of Evans Blue
A 6 or 3% EB w/v solution ͑Sigma, Saint Louis, Missouri͒ was prepared by dilution of the dye in phosphate-buffered saline ͑PBS, pH 7.5͒. Before injection, the solution was filtered through a 5-m filter. An intravenous injection of EB was made to either of the dorsal veins of the tail. The injection lasted for about 10 to 20 s.
Spatially Continuous Capillary Imaging Using Evans Blue as a Contrast Agent
Two irradiation wavelengths 570 and 610 nm were chosen for RBC imaging and EB imaging, respectively. An area of 2 ϫ 2 mm was chosen as the field of interest ͑FOI͒ near the margin of the nude mouse ear, where the capillary density was higher. Before the dye injection, control images were acquired with a scanning step size of 2.5 m at 570 and 610 nm. The total scanning time for a complete volumetric dataset was ϳ30 min for each wavelength. To get sufficient imaging contrast and sensitivity of the capillaries, a relatively high concentration of EB in the blood plasma should be reached. Here 0.2 mL of 6% EB solution was injected in a nude mouse ͑body weight ϳ20 g͒. The total blood volume of the mouse was about 1.2 mL. 29 Thus the concentration of EB in the blood stream was ϳ1%, corresponding to an absorption coefficient of ϳ1000 cm −1 at 610 nm, 30 which is ϳ20 times higher than that of blood ͑ϳ50 cm −1 ͒. Two PA images at 610 nm were acquired, one immediately after the dye injection and the other 30 min later. Transmission optical microscopic images at 4ϫ magnification were acquired before and after injection.
Dynamics of Evans Blue Diffusion Out of the Blood Stream
EB is removed from the vascular system principally by diffusing into extravascular tissue. At high dye concentrations, in the first few hours, it is mainly the free EB rather than the EB-albumin complex that diffuses out. The fixation of the free EB molecules by tissue proteins causes more dye to leave the blood to maintain chemical equilibrium, until the tissue proteins become saturated. [24] [25] [26] [27] 31 To better understand the diffusion dynamics, we monitored the dye diffusion over time and quantified the diffused dye volume in the tissue. Here, a smaller area of 1 ϫ 1 mm was imaged near the margin of the nude mouse ear, so more datasets could be acquired over time due to the shorter scanning time of ϳ10 min. Control images at 570 nm 610 nm were acquired before dye injection. After 0.1 mL of 6% EB solution was injected, the dye molar concentration in the plasma was ϳ0.52 mM, which was a high concentration compared with the combination capability of albumin. 27 Right after injection, serial images at 610 nm were acquired every 20 min until the dye diffusion was observed to have reached saturation.
Dynamics of the Evans Blue Albumin Clearance
At low dye concentrations, EB exists almost exclusively in the form of EBA. 27 EB permeates wherever albumin is present. Therefore, the clearance dynamics of the EBA may be used to estimate the albumin metabolic rate in tissue. 27 To better understand the clearance dynamics, in our work the EBA volume in the tissue was monitored by PA imaging. An imaging area of 1 ϫ 1 mm was chosen on the nude mouse ear, and control images at 570 and 610 nm were acquired before dye injection. Then 0.05 mL of 3% EB solution was injected via the tail vein. Serial images were acquired at 610 nm every one or two days, until EBA had almost completely cleared out.
Quantitative Data Processing
All the data processing in this work was based on the volumetric datasets. A typical 3-D data cube in this work consists of 200ϫ 400ϫ 400 voxels for a 1 ϫ 1-mm scanning area, or 200ϫ 800ϫ 800 voxels for a 2 ϫ 2-mm scanning area. Each voxel equals a physical size of 7.5ϫ 2.5ϫ 2.5 m. Hilbert transformation was performed along each A-line to extract the amplitude information. For visualization, a maximum amplitude projection ͑MAP͒ image was obtained by projecting the maximum value of each A-line onto the transverse scanning ͑x-y͒ plane. The EB or EBA volume was estimated by counting the voxels.
Results
Spatially Continuous Capillary Imaging Using Evans Blue as a Contrast Agent
In this study, EB solution ͑6%, 0.2 mL͒ was injected into the blood circulation system of the nude mouse. Before dye injection, a PA image was acquired at 570 nm ͓Fig. 1͑a͔͒. Hemoglobin has strong absorption at this wavelength, which provided high imaging contrast and a high signal-to-noise ratio ͑ Ͼ 40 dB͒. Veins and arteries larger than 10 m in diameter contained a higher area density of RBCs and appeared uniformly bright. However, smaller capillaries, containing a single of RBCs, looked discontinuous and fragmentary ͓see the arrows in Fig. 1͑a͔͒ . As a control, another image was acquired at 610 nm ͓Fig. 1͑b͔͒. The signal was very weak due to the low hemoglobin absorption at 610 nm, which was only one-twentieth of that at 570 nm. Right after the dye injection, the microvascular network appeared continuous, as shown in Fig. 1͑c͒ . Dense capillaries could be observed, as indicated by arrows. All the capillaries that appear "broken" in Fig. 1͑a͒ became smooth and continuous ͑Video 1͒. Moreover, the capillary branching points that were invisible in Fig. 1͑a͒ could be clearly distinguished. The blood vessels in Fig. 1͑c͒ appear somewhat thicker than those in Fig. 1͑a͒ , which was possibly because the plasma volume was larger than the RBC volume.
The discernable blood vessel volume in the plasma-based image appeared to be more than 50% greater than that disclosed in the RBC-based image. The image in Fig. 1͑d͒ was acquired at 610 nm 30 min after dye injection. It shows that a considerable amount of EB had diffused out of the blood vessels into the surrounding tissue but did not diffuse into the sebaceous glands, which appear as brown patches in the transmission microscopic images ͓see arrows in Figs. 1͑d͒-1͑f͔͒.
Dynamics of Evans Blue Diffusion Out of the Blood Stream
As before, control images at 570 and 610 nm were acquired before dye injection ͓Figs. 2͑a͒ and 2͑b͔͒. The whole microvascular network within the field of view showed up with denser and more continuous capillaries right after the 0.1 mL Fig. 1 EB enhanced photoacoustic imaging of mouse ear microvessels. PA microvascular image before dye injection acquired at ͑a͒ 570 nm and at ͑b͒ 610 nm. Arrows in ͑a͒ point to the fragmentary capillaries. ͑c͒ PA image acquired at 610 nm right after EB ͑6%, 0.2 mL͒ injection via tail vein. Arrows in ͑c͒ point to the continuous capillaries. ͑d͒ PA image acquired at 610 nm acquired 30 min after injection. Transmission microscopic images of the same area ͑e͒ before and ͑f͒ after injection. Arrows in ͑d͒, ͑e͒, and ͑f͒ point to sebaceous glands. All the photoacoustic images were scaled to the same level of PA signal.
Video 1 A volumetric visualization of the images before dye injection at 570 nm and after dye injection at 610 nm ͑MOV, 0.9 MB͒. ͓URL: http://dx.doi.org/10.1117/1.3251044.1͔. Fig. 2 Dynamics of EB diffusion out of the blood stream into surrounding tissue. PA images acquired before EB injection at ͑a͒ 570 nm and at ͑b͒ 610 nm ͑c͒ through ͑g͒ PA images acquired at 610 nm after EB ͑6%, 0.1 mL͒ injection at different times. ͑h͒ Partial volume of EB diffused into surrounding tissue. An exponential recovery model was used to fit the experiment data. All the photoacoustic images were scaled to the same level.
of 6% EB solution was injected ͓Fig. 2͑c͔͒. Sequential images were acquired at different time points from 30 to 120 min ͓Figs. 2͑d͒-2͑g͒; Video 2͔. The partial volume of the free EB molecule diffused into extravascular tissue increased gradually and reached a plateau after ϳ2 h. If the dye left the blood vessels in a passive diffusion pattern, the extravascular dye volume could be fitted by an exponential recovery model.
where Q T ͑t͒ and Q e are the dye volumes at time t and equilibrium, respectively, and k is the dye diffusion rate. The fit result shows that EB indeed diffused in a passive pattern ͓Fig. 2͑h͔͒. However, EB did not diffuse into the sebaceous glands, so more and more dark cavities were formed as the diffusion went on. Blood vessels were embedded in the diffused dye and capillaries became nearly invisible.
Dynamics of Evans Blue Albumin Clearance
To study the EBA clearance in vivo, 0.05 mL of 3% EB solution was injected. Before dye injection, Fig. 3͑a͒ was acquired at 610 nm as a control image. Figures 3͑b͒-3͑i͒ were acquired on different days after dye injection ͑Video 3͒. The EBA volume out of the blood vessels was calculated. Quantified clearance is shown in Fig. 4 . The EBA volume in the extravascular tissue reached maximum on day 3 and then decreased to the base line by day 10. A two-compartment model was used to fit the EBA volume in the extravascular tissue.
where Q V and Q T are the EBA volumes in the blood stream and extravascular tissue, respectively. k 1 is the diffusion rate of EBA from the blood stream into the extravascular tissue, and k 2 is the clearance rate of EBA in the tissue. The results were consistent with the standard histological studies of long term EBA decline.
31,33
Discussion
In this work, we demonstrate the feasibility of using Evans blue dye as a contrast agent to enhance in vivo photoacoustic microvascular imaging. Complete and continuous microvascular networks, especially capillaries, were imaged with the contrast of EB. And to the best of our knowledge, it is the first time that PA imaging has been used to study the dynamics of EB diffusion and EBA clearance.
Video 2 A volumetric visualization of the dynamics of EB diffusion at 610 nm ͑QuickTime,0.9 MB͒. ͓URL: http://dx.doi.org/10.1117/1.3251044.2͔. Fig. 3 Clearance dynamics of EBA. Before EB injection, ͑a͒ was acquired at 610 nm. On 1 2 to 10 days following EB ͑3%, 0.05 mL͒ injection, images ͑b͒ through ͑i͒ were acquired at 610 nm. All the photoacoustic images were scaled to the same level. The photobleaching of EB may be crucial for quantitative study. In a previous study, 30 for a pulsed Nd:YAG laser ͑532 nm, 50 Hz, 14-ns pulse͒ and static 0.3% EB solution, photobleaching started after 1-min irradiation with an energy deposition of 20 mJ/ pulse cm 2 . In our study, the energy pulse deposition was about 100 mJ/ pulse cm 2 . However, the irradiation time was only 7 ns at each imaging position, which is much shorter than the reported photobleaching exposure time. Therefore, the influence of photobleaching on the quantitative study can be ignored, and the possibility that the apparent clearance of the dye was caused by photobleaching can be excluded.
At high EB concentrations, it is mainly the free dye that passively diffuses out of the blood vessels over tens of minutes. At low EB concentrations, as in most biological applications, 15, 20, 22, 33, 34 it is mainly the EBA that diffuses out of the blood vessels, and thus it is usually used as an indicator of the vessel leakage level. Our study was implemented under baseline conditions, where the blood vessel was leakage resistant for albumin, so relatively high EB concentrations were used here to study the dynamics. However, a high contrast PA image does not depend on whether free EB dye or EBA caused dye diffusion into extravascular tissue. The key point here is that the potential application of PA imaging combined with EB for physiological and pathological studies has been well demonstrated. Moreover, to test the imaging sensitivity, a commonly used EB injection dose ͑30-mg/ kg body weight͒ was used ͑Fig. 5, Video 4͒. The diffused EBA can be clearly observed due to the high absorption contrast between the dyeprotein complex and background tissue, hence the imaging sensitivity is sufficient for the biological applications.
It is interesting that EB and EBA did not diffuse into the sebaceous glands, where dark cavities were formed in the PA images, possibly caused by the denser structure or the biochemical properties of the sebaceous glands. The physiological characteristics of sebaceous glands have been thoroughly studied. 35 PA imaging facilitated by EB can provide 3-D structural and functional information of sebaceous glands, which are very important growth indexes during carcinoma development.
Fig. 5
Imaging sensitivity when a low concentration of EB was used. The image was acquired at 570 nm on day 2 after 0.02 mL of 0.3% EB solution was injected. BV is the blood vessel and SG is the sebaceous gland.
Video 4 A volumetric visualization of the image by using low concentration EB ͑QuickTime, 1.4 MB͒. ͓URL: http://dx.doi.org/10.1117/1.3251044.4͔.
